Edgen Stock·Nov 21 2025, 21:35返回
返回
Tango Therapeutics在積極癌症數據後將Vopimetostat推進至關鍵試驗
Edgen Stock·Nov 21 2025, 21:35
[1] Tango報告vopimetostat在MTAP缺失型癌症中的積極數據 (https://www.investing.com/news/company-news/t ...)[2] Tango Therapeutics公佈正在進行的1/2期積極數據... (https://www.theglobeandmail.com/investing/mar ...)[3] 為什麼Tango Therapeutics (TNGX)在Vopimetostat積極數據後飆升... (https://finance.yahoo.com/news/why-tango-ther ...)